Cargando…

Antibodies to Antigenic Site A of Influenza H7 Hemagglutinin Provide Protection against H7N9 Challenge

Identifying major antigenic and protective epitopes of the H7 hemagglutinin (HA) will be important for understanding the antibody response to vaccines developed against the novel influenza H7N9 viruses that emerged in China in 2013. To facilitate antigenic characterization of the H7N9 HA and to deve...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schmeisser, Falko, Vasudevan, Anupama, Verma, Swati, Wang, Wei, Alvarado, Esmeralda, Weiss, Carol, Atukorale, Vajini, Meseda, Clement, Weir, Jerry P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4309539/ https://www.ncbi.nlm.nih.gov/pubmed/25629172 http://dx.doi.org/10.1371/journal.pone.0117108

Ejemplares similares

Neutralizing and protective murine monoclonal antibodies to the hemagglutinin of influenza H5 clades 2.3.2.1 and 2.3.4.4
por: Schuele, Carlotta, et al.
Publicado: (2023)

Immunogenicity and Protection Against Influenza H7N3 in Mice by Modified Vaccinia Virus Ankara Vectors Expressing Influenza Virus Hemagglutinin or Neuraminidase
por: Meseda, Clement A., et al.
Publicado: (2018)

Percutaneous Vaccination as an Effective Method of Delivery of MVA and MVA-Vectored Vaccines
por: Meseda, Clement A., et al.
Publicado: (2016)

Glycosylation of Residue 141 of Subtype H7 Influenza A Hemagglutinin (HA) Affects HA-Pseudovirus Infectivity and Sensitivity to Site A Neutralizing Antibodies
por: Alvarado-Facundo, Esmeralda, et al.
Publicado: (2016)

Potency determination of inactivated H7 influenza vaccines using monoclonal antibody‐based ELISA and biolayer interferometry assays
por: Vasudevan, Anupama, et al.
Publicado: (2017)

Stability of the HSV-2 US-6 Gene in the del II, del III, CP77, and I8R-G1L Sites in Modified Vaccinia Virus Ankara After Serial Passage of Recombinant Vectors in Cells
por: Atukorale, Vajini N., et al.
Publicado: (2020)

Generation of a protective murine monoclonal antibody against the stem of influenza hemagglutinins from group 1 viruses and identification of resistance mutations against it
por: Wang, Wei, et al.
Publicado: (2019)

Determination of influenza B identity and potency in quadrivalent inactivated influenza vaccines using lineage-specific monoclonal antibodies
por: Verma, Swati, et al.
Publicado: (2017)

Neutralizing and protective epitopes of the 2009 pandemic influenza H1N1 hemagglutinin
por: Schmeisser, Falko, et al.
Publicado: (2012)

A monoclonal antibody-based immunoassay for measuring the potency of 2009 pandemic influenza H1N1 vaccines
por: Schmeisser, Falko, et al.
Publicado: (2014)

DNA immunization with a herpes simplex virus 2 bacterial artificial chromosome()
por: Meseda, Clement A., et al.
Publicado: (2004)

A novel approach for preparation of the antisera reagent for potency determination of inactivated H7N9 influenza vaccines
por: Schmeisser, Falko, et al.
Publicado: (2016)

Highly pathogenic avian influenza A/Guangdong/17SF003/2016 is immunogenic and induces cross-protection against antigenically divergent H7N9 viruses
por: Radvak, Peter, et al.
Publicado: (2021)

Inhibition of Influenza H7 Hemagglutinin-Mediated Entry
por: Antanasijevic, Aleksandar, et al.
Publicado: (2013)

Conformational Stability of the Hemagglutinin of H5N1 Influenza A Viruses Influences Susceptibility to Broadly Neutralizing Stem Antibodies
por: Wang, Wei, et al.
Publicado: (2018)

Characterization of A/H7 influenza virus global antigenic diversity and key determinants in the hemagglutinin globular head mediating A/H7N9 antigenic evolution
por: Kok, Adinda, et al.
Publicado: (2023)

Transient Expression of Hemagglutinin Antigen from Low Pathogenic Avian Influenza A (H7N7) in Nicotiana benthamiana
por: Kanagarajan, Selvaraju, et al.
Publicado: (2012)

Development of Rapid Immunochromatographic Test for Hemagglutinin Antigen of H7 Subtype in Patients Infected with Novel Avian Influenza A (H7N9) Virus
por: Kang, Keren, et al.
Publicado: (2014)

A DNA Vaccine That Targets Hemagglutinin to Antigen-Presenting Cells Protects Mice against H7 Influenza
por: Andersen, Tor Kristian, et al.
Publicado: (2017)

Incorporation of a lambda phage recombination system and EGFP detection to simplify mutagenesis of Herpes simplex virus bacterial artificial chromosomes
por: Schmeisser, Falko, et al.
Publicado: (2007)

Development of influenza A(H7N9) candidate vaccine viruses with improved hemagglutinin antigen yield in eggs
por: Ridenour, Callie, et al.
Publicado: (2015)

Host shifts and molecular evolution of H7 avian influenza virus hemagglutinin
por: Lebarbenchon, Camille, et al.
Publicado: (2011)

Recombinant influenza H7 hemagglutinins induce lower neutralizing antibody titers in mice than do seasonal hemagglutinins
por: Blanchfield, Kristy, et al.
Publicado: (2014)

Analysis of Adaptation Mutants in the Hemagglutinin of the Influenza A(H1N1)pdm09 Virus
por: Jiménez-Alberto, Alicia, et al.
Publicado: (2013)

Quantitative Description of Glycan-Receptor Binding of Influenza A Virus H7 Hemagglutinin
por: Srinivasan, Karunya, et al.
Publicado: (2013)

Contemporary Avian Influenza A Virus Subtype H1, H6, H7, H10, and H15 Hemagglutinin Genes Encode a Mammalian Virulence Factor Similar to the 1918 Pandemic Virus H1 Hemagglutinin
por: Qi, Li, et al.
Publicado: (2014)

220 mutation in the hemagglutinin of avian influenza A (H7N9) virus alters antigenicity during vaccine strain development
por: Liu, Liqi, et al.
Publicado: (2018)

Amino Acid Residue 217 in the Hemagglutinin Glycoprotein Is a Key Mediator of Avian Influenza H7N9 Virus Antigenicity
por: Chang, Pengxiang, et al.
Publicado: (2018)

Correction: Quantitative Description of Glycan-Receptor Binding of Influenza A Virus H7 Hemagglutinin
por: Srinivasan, Karunya, et al.
Publicado: (2013)

H7 Hemagglutinin nanoparticles retain immunogenicity after >3 months of 25°C storage
por: Chang, Timothy Z., et al.
Publicado: (2018)

Composition of the Hemagglutinin Polybasic Proteolytic Cleavage Motif Mediates Variable Virulence of H7N7 Avian Influenza Viruses
por: Abdelwhab, E. M., et al.
Publicado: (2016)

Antigenic structure of the hemagglutinin of H9N2 influenza viruses
por: Okamatsu, Masatoshi, et al.
Publicado: (2008)

Characterization of the Sialic Acid Binding Activity of Influenza A Viruses Using Soluble Variants of the H7 and H9 Hemagglutinins
por: Sauer, Anne-Kathrin, et al.
Publicado: (2014)

Can high-pathogenic avian influenza viruses with novel hemagglutinin serotypes other than H5 or H7 emerge?
por: Stech, Jürgen, et al.
Publicado: (2012)

Adjuvanted recombinant hemagglutinin H7 vaccine to highly pathogenic influenza A(H7N9) elicits high and sustained antibody responses in healthy adults
por: Oshansky, Christine M., et al.
Publicado: (2021)

Computational approach for predicting the conserved B-cell epitopes of hemagglutinin H7 subtype influenza virus
por: Wang, Xiangyu, et al.
Publicado: (2016)

Simultaneous and automated detection of influenza A virus hemagglutinin H7 and H9 based on magnetism and size mediated microfluidic chip
por: Wang, Shuibing, et al.
Publicado: (2020)

Influenza H7N9 Virus Hemagglutinin with T169A Mutation Possesses Enhanced Thermostability and Provides Effective Immune Protection against Lethal H7N9 Virus Challenge in Chickens
por: Chen, Taoran, et al.
Publicado: (2023)

Variable impact of the hemagglutinin polybasic cleavage site on virulence and pathogenesis of avian influenza H7N7 virus in chickens, turkeys and ducks
por: Scheibner, David, et al.
Publicado: (2019)

Development and optimized pairing of mouse monoclonal antibodies for detecting hemagglutinin in novel H7 subtype influenza viruses
por: Wang, Huijuan, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_pe5tenlp1jlb7o09j0r9v1brh9